The Asia Pacific Glycated Albumin Assay Market would witness market growth of 9.2% CAGR during the forecast period (2023-2030).
Diabetic people have higher levels of protein glycation than non-diabetic patients, glycated proteins can be utilized as a measure of glycemic management. Short-term and postprandial plasma glucose variations are reliably reflected by glycated albumin (GA). Since the glycated albumin assay technique is used to diagnose diabetes, the rising prevalence of the disease is anticipated to fuel market expansion over the coming years. For example, a study by the National Center for Biotechnology Information (NCBI) in October 2021 said that the prevalence of diabetes in India increased from 7.1% in 2009 to 8.9% in 2019.
The market will also profit from the aging populations in developed and developing nations. As the senior population is predicted to increase significantly, it is anticipated that age-related ailments, including diabetes and pancreatic problems, will become significantly more common. Diagnosing and managing such conditions result in many test prescriptions to measure levels of creatinine, albumin, glucose, ketones, and bilirubin, which drives the market's growth.
The prevalence of obesity & overweight, both of which are risk factors for Type 2 diabetes, is increasing in China as a result of bad diets and a lack of exercise. In China, 7% of adults are obese and more than a third are overweight. Children in China are also at risk for developing diabetes as a result of their unhealthy lifestyles, as more than 4 in 5 teenagers between the ages of 11 and 17 do not engage in enough physical exercise, and the prevalence of childhood obesity and overweight is rising quickly. China has the greatest prevalence of Diabetes, as reported by the seventh edition of the International Diabetes Federation (IDF) Diabetes Atlas (11.43 cr.). China has the largest incidence of Diabetes, predominantly type 2, among all nations (114 million), with type 2 being the majority. The high rate of Diabetes will create enormous growth opportunities for market.
The China market dominated the Asia Pacific Glycated Albumin Assay Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $27,799.2 Thousands by 2030. The Japan market is registering a CAGR of 8.5% during (2023 - 2030). Additionally, The India market would showcase a CAGR of 9.9% during (2023 - 2030).
Based on Application, the market is segmented into Type 2 Diabetes, Type 1 Diabetes, and Prediabetes. Based on End User, the market is segmented into Hospitals & Diabetic Care Center, Diagnostic Laboratory, and Others. Based on countries, the market is segmented into China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific.
Free Valuable Insights: The Worldwide Glycated Albumin Assay Market is Projected to reach USD 384.5 Million by 2030, at a CAGR of 8.4%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Asahi Kasei Pharma Corporation (Asahi Kasei Corporation), EKF Diagnostics Holdings plc, Weldon Biotech India Private Limited, Hzymes Biotechnology Co., Ltd., Beijing Strong Biotechnologies, Inc., Diazyme Laboratories, Inc. (General Atomics), Abbexa Limited, Biomatik Corporation, Abnova Corporation and Geno Technology, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Application
- Type 2 Diabetes
- Type 1 Diabetes
- Prediabetes
By End User
- Hospitals & Diabetic Care Center
- Diagnostic Laboratory
- Others
By Country
- China
- Japan
- India
- South Korea
- Singapore
- Malaysia
- Rest of Asia Pacific
Key Market Players
List of Companies Profiled in the Report:
- Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
- EKF Diagnostics Holdings plc
- Weldon Biotech India Private Limited
- Hzymes Biotechnology Co., Ltd.
- Beijing Strong Biotechnologies, Inc.
- Diazyme Laboratories, Inc. (General Atomics)
- Abbexa Limited
- Biomatik Corporation
- Abnova Corporation
- Geno Technology, Inc.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Asia Pacific Glycated Albumin Assay Market, by Application
1.4.2 Asia Pacific Glycated Albumin Assay Market, by End User
1.4.3 Asia Pacific Glycated Albumin Assay Market, by Country
1.5 Methodology for the research
Chapter 2. Market At a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Asia Pacific Glycated Albumin Assay Market by Application
4.1 Asia Pacific Type 2 Diabetes Market by Country
4.2 Asia Pacific Type 1 Diabetes Market by Country
4.3 Asia Pacific Prediabetes Market by Country
Chapter 5. Asia Pacific Glycated Albumin Assay Market by End User
5.1 Asia Pacific Hospitals & Diabetic Care Center Market by Country
5.2 Asia Pacific Diagnostic Laboratory Market by Country
5.3 Asia Pacific Others Market by Country
Chapter 6. Asia Pacific Glycated Albumin Assay Market by Country
6.1 China Glycated Albumin Assay Market
6.1.1 China Glycated Albumin Assay Market by Application
6.1.2 China Glycated Albumin Assay Market by End User
6.2 Japan Glycated Albumin Assay Market
6.2.1 Japan Glycated Albumin Assay Market by Application
6.2.2 Japan Glycated Albumin Assay Market by End User
6.3 India Glycated Albumin Assay Market
6.3.1 India Glycated Albumin Assay Market by Application
6.3.2 India Glycated Albumin Assay Market by End User
6.4 South Korea Glycated Albumin Assay Market
6.4.1 South Korea Glycated Albumin Assay Market by Application
6.4.2 South Korea Glycated Albumin Assay Market by End User
6.5 Singapore Glycated Albumin Assay Market
6.5.1 Singapore Glycated Albumin Assay Market by Application
6.5.2 Singapore Glycated Albumin Assay Market by End User
6.6 Malaysia Glycated Albumin Assay Market
6.6.1 Malaysia Glycated Albumin Assay Market by Application
6.6.2 Malaysia Glycated Albumin Assay Market by End User
6.7 Rest of Asia Pacific Glycated Albumin Assay Market
6.7.1 Rest of Asia Pacific Glycated Albumin Assay Market by Application
6.7.2 Rest of Asia Pacific Glycated Albumin Assay Market by End User
Chapter 7. Company Profiles
7.1 Asahi Kasei Pharma Corporation (Asahi Kasei Corporation)
7.1.1 Company Overview
7.1.2 SWOT Analysis
7.1.3 Financial Analysis
7.1.4 Segmental and Regional Analysis
7.1.5 Research & Development Expenses
7.2 EKF Diagnostics Holdings plc
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expenses
7.2.5 SWOT Analysis
7.3 Weldon Biotech India Private Limited
7.3.1 Company Overview
7.3.2 SWOT Analysis
7.4 Hzymes Biotechnology Co., Ltd.
7.4.1 Company Overview
7.5 Beijing Strong Biotechnologies, Inc.
7.5.1 Company Overview
7.5.2 SWOT Analysis
7.6 Abbexa Limited
7.6.1 Company Overview
7.6.2 SWOT Analysis
7.7 Biomatik Corporation
7.7.1 Company Overview
7.7.2 SWOT Analysis
7.8 Abnova Corporation
7.8.1 Company Overview
7.8.2 SWOT Analysis
7.9 Geno Technology, Inc.
7.9.1 Company Overview
7.9.2 SWOT Analysis
7.10. Diazyme Laboratories, Inc. (General Atomics)
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Partnerships, Collaborations, and Agreements:
7.10.3 SWOT Analysis
TABLE 1 Asia Pacific Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 2 Asia Pacific Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 3 Asia Pacific Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 4 Asia Pacific Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 5 Asia Pacific Type 2 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 6 Asia Pacific Type 2 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 7 Asia Pacific Type 1 Diabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 8 Asia Pacific Type 1 Diabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 9 Asia Pacific Prediabetes Market by Country, 2019 - 2022, USD Thousands
TABLE 10 Asia Pacific Prediabetes Market by Country, 2023 - 2030, USD Thousands
TABLE 11 Asia Pacific Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 12 Asia Pacific Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 13 Asia Pacific Hospitals & Diabetic Care Center Market by Country, 2019 - 2022, USD Thousands
TABLE 14 Asia Pacific Hospitals & Diabetic Care Center Market by Country, 2023 - 2030, USD Thousands
TABLE 15 Asia Pacific Diagnostic Laboratory Market by Country, 2019 - 2022, USD Thousands
TABLE 16 Asia Pacific Diagnostic Laboratory Market by Country, 2023 - 2030, USD Thousands
TABLE 17 Asia Pacific Others Market by Country, 2019 - 2022, USD Thousands
TABLE 18 Asia Pacific Others Market by Country, 2023 - 2030, USD Thousands
TABLE 19 Asia Pacific Glycated Albumin Assay Market by Country, 2019 - 2022, USD Thousands
TABLE 20 Asia Pacific Glycated Albumin Assay Market by Country, 2023 - 2030, USD Thousands
TABLE 21 China Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 22 China Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 23 China Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 24 China Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 25 China Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 26 China Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 27 Japan Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 28 Japan Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 29 Japan Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 30 Japan Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 31 Japan Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 32 Japan Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 33 India Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 34 India Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 35 India Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 36 India Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 37 India Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 38 India Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 39 South Korea Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 40 South Korea Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 41 South Korea Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 42 South Korea Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 43 South Korea Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 44 South Korea Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 45 Singapore Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 46 Singapore Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 47 Singapore Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 48 Singapore Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 49 Singapore Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 50 Singapore Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 51 Malaysia Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 52 Malaysia Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 53 Malaysia Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 54 Malaysia Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 55 Malaysia Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 56 Malaysia Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 57 Rest of Asia Pacific Glycated Albumin Assay Market, 2019 - 2022, USD Thousands
TABLE 58 Rest of Asia Pacific Glycated Albumin Assay Market, 2023 - 2030, USD Thousands
TABLE 59 Rest of Asia Pacific Glycated Albumin Assay Market by Application, 2019 - 2022, USD Thousands
TABLE 60 Rest of Asia Pacific Glycated Albumin Assay Market by Application, 2023 - 2030, USD Thousands
TABLE 61 Rest of Asia Pacific Glycated Albumin Assay Market by End User, 2019 - 2022, USD Thousands
TABLE 62 Rest of Asia Pacific Glycated Albumin Assay Market by End User, 2023 - 2030, USD Thousands
TABLE 63 Key Information – Asahi Kasei Pharma Corporation
TABLE 64 Key Information – EKF Diagnostics Holdings plc
TABLE 65 Key Information – Weldon Biotech India Private Limited
TABLE 66 Key Information – Hzymes Biotechnology Co., Ltd.
TABLE 67 Key Information – Beijing Strong Biotechnologies, Inc.
TABLE 68 Key Information – Abbexa Limited
TABLE 69 Key Information – Biomatik Corporation
TABLE 70 Key Information – Abnova Corporation
TABLE 71 Key Information – Geno Technology, Inc.
TABLE 72 Key Information – Diazyme Laboratories, Inc.
List of Figures
FIG 1 Methodology for the research
FIG 2 Asia Pacific Glycated Albumin Assay Market, 2019 - 2030, USD Thousands
FIG 3 Key Factors Impacting the Glycated Albumin Assay Market
FIG 4 Porter’s Five Forces Analysis – Glycated Albumin Assay Market
FIG 5 Asia Pacific Glycated Albumin Assay Market share by Application, 2022
FIG 6 Asia Pacific Glycated Albumin Assay Market share by Application, 2030
FIG 7 Asia Pacific Glycated Albumin Assay Market by Application, 2019 - 2030, USD Thousands
FIG 8 Asia Pacific Glycated Albumin Assay Market share by End User, 2022
FIG 9 Asia Pacific Glycated Albumin Assay Market share by End User, 2030
FIG 10 Asia Pacific Glycated Albumin Assay Market by End User, 2019 - 2030, USD Thousands
FIG 11 Asia Pacific Glycated Albumin Assay Market share by Country, 2022
FIG 12 Asia Pacific Glycated Albumin Assay Market share by Country, 2030
FIG 13 Asia Pacific Glycated Albumin Assay Market by Country, 2019 - 2030, USD Thousands
FIG 14 SWOT Analysis: Asahi Kasei Pharma Corporation
FIG 15 SWOT Analysis: EKF Diagnostics Holdings plc
FIG 16 SWOT Analysis: Weldon Biotech India Private Limited
FIG 17 SWOT Analysis: Beijing Strong Biotechnologies, Inc.
FIG 18 SWOT Analysis: Abbexa Limited
FIG 19 SWOT Analysis: Biomatik Corporation
FIG 20 SWOT Analysis: Abnova Corporation
FIG 21 SWOT Analysis: Geno Technology, Inc.
FIG 22 SWOT Analysis: Diazyme Laboratories, Inc.